Panion and BF Biotech Inc. authorised exclusive distributor, DKSH (Thailand) Limited successfully obtained Nephoxil NDA from Thai Food and Drug Administration-Thai FDA. Developing New Drug Name or Code: Nephoxil 500mg Capsule. Indication: control of hyperphosphatemia in adult patients with chronic kidney disease undergoing hemodialysis.

Undergoing Researching Stages: Successfully obtained Nephoxil NDAfrom Thai Food and Drug Administration- Thai FDA). Accumulated R&D Researching Fund: N/A. Market Insights: According to Thai media report, there is approximately 7.6 million people with kidney failure and there is approximately 11.6 million people with chronic kidney disease, in which there is an estimate of over 100 thousand people requiring hemodialysis treatment.